• Molecular NameDopamine
  • SynonymDA; Deoxyepinephrine; Dopamin; Dopamine HCl; Dophamine; Hydroxytyramin; Hydroxytyramine; Oxytyramine
  • Weight153.181
  • Drugbank_IDDB00988
  • ACS_NO51-61-6
  • Show 3D model
  • LogP (experiment)0.548
  • LogP (predicted, AB/LogP v2.0)0.14
  • pka8.8, 10.6
  • LogD (pH=7, predicted)-1.46
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.64
  • LogSw (predicted, AB/LogsW2.0)13.11
  • Sw (mg/ml) (predicted, ACD/Labs)9.17
  • No.of HBond Donors4
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds2
  • TPSA66.48
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA neurotransmitter that occurs in a wide variety of animals, including both vertebrates and invertebrates.
  • Absorption_valueN/A
  • Absorption (description)Dopamine is a naturally occurring catecholamine and is considered to be the metabolic precursor of noradrenaline. It is inactivated after oral administration.
  • Caco_2N/A
  • Bioavailability20.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmIt is excreted mainly as 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid); noradrenaline (norepinephrine) and 3-methoxytyramine are also metabolites. Dopamine is a metabolite of levodopa.
  • Half life2 min
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySpasm or closing of eyelids, nausea, vomiting, cardiac arrhythmias, involuntary movements of the body including the face, tongue, arms, hand, head, and upper body; hypotension, haemolytic anaemia, urinary retention, duodenal ulcer, sialorrhea, ataxia, abdominal pain, dry mouth, nightmares, tachypnoea, bruxism, confusion, and insomnia.
  • LD50 (rat)1780 mg/kg
  • LD50 (mouse)1460 mg/kg